2023

2023

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

de Matos Simoes R.;Shirasaki R.;Downey-Kopyscinski S.L.;Matthews G.M.;Barwick B.G.;Gupta V.A.;Dupéré-Richer D.;Yamano S.;Hu Y.;Sheffer M.;Dhimolea E.;Dashevsky O.;Gandolfi S.;Ishiguro K.;Meyers R.M.;Bryan J.G.;Dharia N.V.;Hengeveld P.J.;Brüggenthies J.B.;Tang H.;Aguirre A.J.;Sievers Q.L.;Ebert B.L.;Glassner B.J.;Ott C.J.;Bradner J.E.;Kwiatkowski N.P.;Auclair D.;Levy J.;Keats J.J.;Groen R.W.J.;Gray N.S.;Culhane A.C.;McFarland J.M.;Dempster J.M.;Licht J.D.;Boise L.H.;Hahn W.C.;Vazquez F.;Tsherniak A.;Mitsiades C.S. (2023) Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nature Cancer :754-773